Rheumatology
Cosentyx Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Cosentyx® (secukinumab injection).
Cosentyx® (secukinumab) is a fully human monoclonal antibody that selectively binds and neutralizes IL-17A, indicated for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and enthesitis-related arthritis.
Built to help reduce friction around treatment access & patient care.
Request Cosentyx® (secukinumab injection) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Cosentyx Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for Cosentyx sample and treatment access support.
Cosentyx® is the brand name for secukinumab, an IL-17A inhibitor indicated for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and related conditions.
Cosentyx® is indicated for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and enthesitis-related arthritis.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.